Together: A Better Way To Fight Cancer
Thousands of patients trust their care to Radiotherapy Clinics of Georgia. Founded in 1984 by renowned radiation oncologist Dr. Frank Critz, Radiotherapy Clinics of Georgia today is a center of excellence in radiation treatment for cancer. We use the latest radiation technology and meticulous research to treat men and women with different types of cancer including breast, prostate, lung, colon, lymphatic and many others. Radiotherapy Clinics of Georgia is also home to the oldest and most successful prostate seed implant program in existence. We’re proud to say that our treatment for prostate cancer, ProstRcision®, has the world’s highest proven cure rate.
Radiotherapy Clinics of Georgia is part of The US Oncology Network, a community of more than 1,400 affiliated physicians with expertise in medical oncology, hematology, radiation oncology, gynecologic oncology, urology, oncology surgery and other specialties. We believe local cancer care is better care. Practices in The Network deliver advanced integrated cancer care supported by a network of independent physicians who share expertise and resources to provide quality, value-based care close to home. The Network practices have more than 400 sites of care in over 25 states and treat over 850,000 patients annually. The Network is supported by McKesson Specialty Health, an industry leader in solutions that empower the community patient care delivery system to advance the science, technology and quality of care.
2349 Lawrenceville Highway
Decatur, GA 30033
- Contact Information
P: (404) 320-1550
F: (404) 728-1081
Radiotherapy Clinics of Georgia began with one location in Conyers, Georgia, a quiet suburb of Atlanta. Over the years, we’ve branched out with offices throughout the metro Atlanta area. As we’ve expanded, our reputation has grown as well. Radiotherapy Clinics of Georgia has become one of the country’s top cancer treatment and research facilities, especially in the area of prostate cancer.
We have treated more than 16,000 men for prostate cancer with ProstRcision. We have compiled our observations of these men, both before and after treatment, into one of the largest computerized databases on prostate cancer in the U.S. In addition, our doctors have written more than 80 peer-reviewed research papers on prostate cancer that have been published or presented at major medical meetings. Each year, thousands of patients from across the United States and around the globe come to us seeking a cure for their cancer.
The physicians at Radiotherapy Clinics of Georgia are some of the finest, most experienced radiation oncologists in the United States. Though their backgrounds differ, each has come to RCOG because they believe that data-driven, evidence-based medicine can save more lives. In addition to being talented practitioners, our physicians are actively involved in the advancement of cancer research. In fact, Radiotherapy Clinics of Georgia is responsible for more published papers on prostate cancer than any other radiation practice in Georgia.
James Benton, MD
James Benton, MD is board certified as a Radiation Oncologist by the American Board of Radiology. Dr. Benton believes in providing quality, personalized cancer care in a community setting, and demonstrates that commitment daily in his patient care activities.
A Magna Cum Laude graduate of Armstrong State University in Savannah, Georgia with a bachelor's degree in Chemistry and Math. Dr. Benton attended Morehouse School of Medicine, where he completed his medical degree and graduated first in his class. He completed a residency in Internal Medicine at the Medical College of Virginia, and a second residency in Radiation Oncology at Emory University.
Dr. Benton’s love of math, physics and science led him to radiation oncology, a specialty he admires for the depth of its technical detail and the breadth of its clinical application. Prior to joining the staff at Radiotherapy Clinics of Georgia in 1998, Dr. Benton served as Chief Resident and Assistant Professor of Radiation Oncology at Emory University. Dr. Benton is a life-time member of the Alpha Omega Alpha Medical Honor Society. This distinction is given out to only 5-10% of medical school graduates throughout the United States.
Dr. Benton practiced as a board certified Internist for a few years before becoming a board certified Radiation Oncologist more than 15 years ago. Currently, he is President of Radiotherapy Clinics of Georgia (RCOG), and he practices at RCOG’s main campus in Decatur, specializing in treating a variety of cancers such as breast, prostate and many other sites. Along with other experts in the field of prostate cancer treatment, Dr. Benton has authored numerous medical research manuscripts and his work has been published in numerous peer review journals.
Medical School: Morehouse School of Medicine/Medical College of Georgia
Residencies: Radiation Oncology Residency – Emory University; Chief Resident, Radiation Oncology – Emory University; Internal Medicine Residency – Medical College of Virginia
Board Certification: American Board of Radiology - Board Certified in Radiation Oncology, Board Certified in Internal Medicine; ACLS Instructor
• American Board of Radiology
• American Society of Therapeutic Radiation Oncology
Voted Top Doctor in Atlanta, Atlanta Magazine, 2016
• Cigarette Smoking Does Not Affect Treatment Results of Simultaneous Irradiation For Prostate Cancer, J.B. Benton, F.A. Critz, A.K. Levinson, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 22:444, 2003.
• Patient Age Related To Prostate Specific Antigen Bound By Recursive Partitioning Analysis After Brachytherapy For Prostate Cancer, F.A. Critz, J.B. Benton, F.J. Schnell, P.D. Shrake, A. Ciampi, A. Couturier. ASCO Proceedings, 22:438, 2003.
• Pretreatment Erectile Function Of Men Who Underwent Brachytherapy For Prostate Cancer, F.J. Schnell, F.A. Critz, J.B. Benton, P.D. Shrake. ASCO Proceedings, 22:444, 2003.
• Probability of Achieving PSA Nadir 0.5 Ng/ml After Radiotherapy of Prostate Cancer, V.Griffin, F. Critz, K. Levinson, J. Benton. ASCO Proceedings, 18:339a, 1999.
• Prostate Cancer in African-American Men Treated by Simultaneous Radiotherapy, F.Critz, K. Levinson, V. Griffin, J. Benton. ASCO Proceedings 18, 1999.
• Prostate Specific Antigen Nadir After Brachytherapy for Prostate Cancer Correlates With Prognosis of Men Who Recur, Frank A. Critz, A. Keith Levinson, James B. Benton, Frederick J. Schnell, and Philip D. Shrake. J Urol 169 (supplement):179, 2003.
• A Standard Definition of Disease Freedom is Needed for Prostate Cancer, F. Critz, J. Benton, F. Schnell, P. Shrake. American Brachytherapy Society Meeting. ABS Proceedings, 1:57, 2001.
• Acute and Late Morbidity Following Simultaneous Irradiation for Prostate Cancer, F.A. Critz, K. Levinson, F. Schnell, J. Benton, P. Shrake. ASCO Proceedings, 20:189a, 2001.
• Disease Free Survival Rates Following Irradiation of Prostate Cancer According to Age, J.B. Benton, F.A. Critz, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 21:167B, 2002.
• Sexual Function Following Simultaneous Irradiation for Prostate Cancer, F.A Critz, J.B. Benton, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 21:188a, 2002.
• Ten-Year Disease Free Survival Rate Calculated With PSA Cutpoint 0.2 ng/ml In Men After Brachytherapy For Prostate Cancer, F.A. Critz, A. Keith Levinson, J. B. Benton, F.J. Schnell, P.D. Shrake. J Urol 169 (supplement):181, 2003.
• Treatment of Gleason Score 7 Prostate Cancer with I-125 Implant Followed by External Beam Radiotherapy, J. Benton, F.A. Critz, K. Levinson, V. Griffin. ASCO Proceedings, 18:317a, 1999.
• Young Men with Prostate Cancer Treated by Simultaneous Radiotherapy, A. A. Sheikh, F.A. Critz, A.K. Levinson, J.B. Benton, F. Schnell, P. Shrake, L.S. Maxa. ASCO Proceedings, 19:227a, 2000.
• Obstructive Uropathy Following Simultaneous Irradiation For Prostate Cancer Measured By A Longitudinal Study of The American Urological Association Symptom Index For Benign Prostate Hyperplasia,
F.A. Critz, A. Keith Levinson, James B. Benton, F.J. Schnell, Philip D. Shrake. ABS Proceedings, 2:67, 2003.
• Postirradiation Prostatitis: A Previously Unrecognized Syndrome Following Brachytherapy For Prostate Cancer, F.A. Critz, A.K. Levinson, J.B. Benton, F.J. Schnell, P.D. Shrake. ABS Proceedings, 2:66, 2003.
Mark Merlin, MD
Mark Merlin, MD is board certified as a Radiation Oncologist by the American Board of Radiology. Dr. Merlin, a Louisiana native, was practicing at a large radiation and medical oncology group in New Orleans before Hurricane Katrina uprooted him and his family to Atlanta. He reached out to Radiotherapy Clinics of Georgia (RCOG) because of its strong reputation in the treatment of prostate cancer, and he has been practicing at RCOG’s Decatur location ever since. Dr. Merlin believes in providing quality, personalized cancer care in a community setting, and demonstrates that commitment daily in his patient care activities.
Following in the footsteps of his father and uncle, Dr. Merlin elected to become a physician. He attended medical school at Louisiana State University and trained at the Medical College of Georgia in Augusta.
“I decided to pursue radiation oncology because I had an interest in caring for patients with cancer and the technology used in treatment,” Dr. Merlin said.
After losing everything in the hurricane, he and his wife and their two children decided to make Georgia their permanent home, filling their spare time with soccer, gymnastics and hiking. He and his wife also compete in triathlons and marathons.
Medical School: Louisiana State University School of Medicine
Internship: Internal Medicine, Medical College of Georgia
Residency: Radiation Onclogy, Medical College of Georgia; Chief Resident, Radiation Oncology – Emory University; Internal Medicine Residency – Medical College of Virginia
Board Certification: American Board of Radiology in Radiation Oncology
• American College of Radiation Oncology
• American Society of Therapeutic Radiation Oncology
• Jefferson Parish Medical Society
• Louisiana Society Radiation Oncology
• New Orleans Radiation Oncology
- Cone Beam CT
- CT Scanning & Simulation
- Eclipse Treatment Planning System
- High Dose Rate Brachytherapy (HDR)
- Image-Guided Radiation Therapy (IGRT)
- Intensity-Modulated Radiation Therapy (IMRT)
- Seed Implants (Low Dose Rate Brachytherapy)
- Stereotactic Body Radiation Therapy (SBRT)
NEW PATIENT CHECKLIST
The patient portal allows patients to manage their personal health information electronically at their own convenience.